Edition:
United States

Flex Pharma Inc (FLKS.OQ)

FLKS.OQ on NASDAQ Stock Exchange Global Market

0.58USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$0.58
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
199,425
52-wk High
$8.95
52-wk Low
$0.40

Chart for

About

Flex Pharma, Inc. is a biotechnology company. The Company develops treatments for nocturnal leg cramps, muscle cramps and spasms associated with severe neuromuscular conditions, and exercise associated muscle cramps (EAMCs). The Company's product candidates activate certain receptors in primary sensory neurons, which then act... (more)

Overall

Beta: 2.43
Market Cap(Mil.): $8.85
Shares Outstanding(Mil.): 18.07
Dividend: --
Yield (%): --

Financials

  FLKS.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -1.95 -- --
ROI: -119.40 1.96 12.83
ROE: -119.61 1.12 14.95

Flex Pharma to scrap two mid-stage neuromuscular disease trials

U.S. drug developer Flex Pharma Inc said on Wednesday it plans to stop two ongoing mid-stage trials, testing its lead drug to treat neuromuscular diseases, following safety concerns.

Jun 13 2018

UPDATE 1-Flex Pharma to scrap two mid-stage neuromuscular disease trials

June 13 U.S. drug developer Flex Pharma Inc said on Wednesday it plans to stop two ongoing mid-stage trials, testing its lead drug to treat neuromuscular diseases, following safety concerns.

Jun 13 2018

Flex Pharma to cut 60 percent of workforce

June 13 U.S. drug developer Flex Pharma Inc said on Wednesday it plans to reduce its workforce by 60 percent, as part of a restructuring, and was ending certain ongoing mid-stage trials.

Jun 13 2018

BRIEF-Flex Pharma Reports Q1 Loss Per Share $0.46

* Q1 EARNINGS PER SHARE VIEW $-0.49 -- THOMSON REUTERS I/B/E/S

May 02 2018

Earnings vs. Estimates